Dorsey Brian 4
4 · ARS Pharmaceuticals, Inc. · Filed Jan 5, 2023
Insider Transaction Report
Form 4
Dorsey Brian
Chief Operating Officer
Transactions
- Award
Stock option (right to buy)
2023-01-03+145,000→ 145,000 totalExercise: $8.42Exp: 2033-01-02→ Common Stock (145,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on January 1, 2024, and the remaining shares will vest monthly thereafter over three years.